Target Price | $28.26 |
Price | $23.45 |
Potential |
20.53%
register free of charge
|
Number of Estimates | 19 |
19 Analysts have issued a price target Pfizer 2026 .
The average Pfizer target price is $28.26.
This is
20.53%
register free of charge
$35.00
49.25%
register free of charge
$23.00
1.92%
register free of charge
|
|
A rating was issued by 26 analysts: 10 Analysts recommend Pfizer to buy, 15 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Pfizer stock has an average upside potential 2026 of
20.53%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 63.63 | 62.48 |
6.84% | 1.81% | |
EBITDA Margin | 34.60% | 39.41% |
15.57% | 13.90% | |
Net Margin | 12.62% | 16.39% |
254.74% | 29.85% |
19 Analysts have issued a sales forecast Pfizer 2025 . The average Pfizer sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Pfizer EBITDA forecast 2025. The average Pfizer EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Pfizer Analysts have issued a net profit forecast 2025. The average Pfizer net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.41 | 1.80 |
281.08% | 27.66% | |
P/E | 12.87 | |
EV/Sales | 2.83 |
5 Analysts have issued a Pfizer forecast for earnings per share. The average Pfizer EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Apr 22 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
UBS |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Feb 10 2025 |
Analyst Rating | Date |
---|---|
Locked
UBS:
Locked
➜
Locked
|
Apr 30 2025 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Apr 22 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
Apr 08 2025 |
Locked
UBS:
Locked
➜
Locked
|
Apr 08 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 18 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 12 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Feb 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.